 |
coagulation factor XIII A-subunit (recombinant) |
|---|---|
| Trade Name | Tretten |
| Orphan Indication | Factor XIII Deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2003-11-06 00:00:00 |
| Sponsor | Novo Nordisk, Inc.;800 Scudders Mill Rd.;Plainsboro, New Jersey, 08536 |
